Sodium Bicarbonate for Acute Metabolic Acidosis in Critically Ill Adults: A Meta-Analysis of Randomized Clinical Trials

Jia-Jin Chen; Tao-Han Lee; Chih-Hsiang Chang; Pei-Chun Lai; Yu-Kang Tu; Yen-Ta Huang

doi:10.1097/CCM.0000000000007179

Sodium Bicarbonate for Acute Metabolic Acidosis in Critically Ill Adults: A Meta-Analysis of Randomized Clinical Trials

Crit Care Med. 2026 May 22. doi: 10.1097/CCM.0000000000007179. Online ahead of print.

Authors

Jia-Jin Chen^{1

2}, Tao-Han Lee³, Chih-Hsiang Chang^{1

2}, Pei-Chun Lai⁴, Yu-Kang Tu⁵, Yen-Ta Huang⁶

Affiliations

¹ Kidney Research Center, Department of Nephrology, Chang Gung Memorial Hospital, Taoyuan city, Taiwan.
² College of Medicine, Chang Gung University, Taoyuan city, Taiwan.
³ Department of Nephrology, Chansn Hospital, Taoyuan City, Taiwan.
⁴ Education Center, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
⁵ Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan.
⁶ Department of Surgery, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.

PMID: 42171427
DOI: 10.1097/CCM.0000000000007179

Abstract

Objectives: Acute metabolic acidosis is frequent in critical illness and may be managed with volume replacement therapy, sodium bicarbonate, and renal replacement therapy (RRT). BICARICU-1 and BICARICU-2 trials provided new evidence on bicarbonate therapy. We aimed to systematically evaluate the effects of sodium bicarbonate in critically ill patients.

Data sources: We systematically searched PubMed, Embase, Medline, and the Cochrane Library for randomized controlled trials (RCTs) evaluating sodium bicarbonate vs. placebo in critically ill adults with acute metabolic acidosis.

Study selection: Only RCTs were selected.

Data extraction: Primary outcome was RRT; secondary outcomes were mortality, ICU length of stay, ventilator-free days, and vasopressor-free days.

Data synthesis: We performed Hartung-Knapp random-effects meta-analyses and trial sequential analysis (TSA) for primary outcomes. Bayesian random-effects meta-analyses with noninformative and weakly informative priors were used for sensitivity analysis. Four trials enrolling 1,111 patients were included. Sodium bicarbonate showed a nonsignificant trend toward lower mortality (risk ratio [RR], 0.84; 95% CI, 0.55-1.30); TSA indicated that the cumulative sample size remained far below the required information size, and the mortality effect is inconclusive. Sodium bicarbonate significantly reduced RRT use (RR, 0.69; 95% CI, 0.61-0.78), and TSA supported firm evidence of benefit. Bayesian analyses estimated posterior probabilities of any mortality reduction (RR < 1) and reduced RRT use of 90.4% and 94.6%, respectively. Secondary outcomes remained imprecise, with a trend of toward more vasopressor-free days.

Conclusions: In critically ill adults with acute metabolic acidosis, sodium bicarbonate significantly reduces RRT requirement, with Bayesian analyses suggesting a possibility of mortality benefit, although current evidence remains inconclusive. Larger RCTs or high-quality real-world studies are needed to confirm efficacy of sodium bicarbonate for mortality.

Keywords: dialysis; mortality; sodium bicarbonate.